← Leaderboards
Janardan P Pandey
Medical University Of South Carolina
$4,092,394
Attributed
$4,092,394
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $679.5K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,092,394 · 8
By mechanism
R21$2,026,985 · 5
R01$1,698,419 · 2
R56$366,990 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAntibodiesInvestigationReceptorGenotypeVirusViralGenesHerpesviridaeComplexImmunityGeneticImmunoglobulin GCandidate Disease GeneAllelesProteinsAffinityMediatingImmune SystemGenotyping TechnologyGenome Wide Association StudyImmunoglobulinsImmunotherapyFc Domain
Grant awards (18)
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease$369,950
R01 · FY2025 · AG · contact PI
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease$377,500
R01 · FY2024 · AG · contact PI
IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-Disease$113,250
R21 · FY2024 · HL · contact PI
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease$377,500
R01 · FY2023 · AG · contact PI
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis$188,750
R21 · FY2023 · EY · contact PI
IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-Disease$113,250
R21 · FY2023 · HL · contact PI
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis$226,500
R21 · FY2022 · EY · contact PI
Immunoglobulin GM (γ marker) Allotypes and Immunity to HSV1 in Alzheimerâs Disease$366,990
R56 · FY2021 · AG · contact PI
Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer Disease$187,861
R21 · FY2018 · AG · contact PI
Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer Disease$149,500
R21 · FY2018 · AG · contact PI
Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer Disease$237,577
R21 · FY2017 · AG · contact PI
Immunoglobulin Genes and Immunoevasion by Neurotropic Viruses in Schizophrenia$186,875
R21 · FY2016 · MH · contact PI
Immunoglobulin Genes and Immunoevasion by Neurotropic Viruses in Schizophrenia$224,250
R21 · FY2015 · MH · contact PI
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma$177,922
R21 · FY2013 · NS · contact PI
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma$221,250
R21 · FY2012 · NS · contact PI
Immunoglobulin Allotypes in Hepatitis C Virus Infection$186,896
R01 · FY2008 · DK · contact PI
Immunoglobulin Allotypes in Hepatitis C Virus Infection$190,604
R01 · FY2007 · DK · contact PI
Immunoglobulin Allotypes in Hepatitis C Virus Infection$195,969
R01 · FY2006 · DK · contact PI